These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 37274914)

  • 1. Isolation and Characterization of Bacteriophages Active against
    Mohamed WF; Askora AA; Mahdy MMH; El-Hussieny EA; Abu-Shady HM
    Arch Razi Inst; 2022 Dec; 77(6):2187-2200. PubMed ID: 37274914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of bactericidal effects of bacteriophage and gentamicin combination regimen against Staphylococcus aureus and Pseudomonas aeruginosa strains in a mice diabetic wound model.
    Jokar J; Abdulabbas HT; Javanmardi K; Mobasher MA; Jafari S; Ghasemian A; Rahimian N; Zarenezhad A; ُSoltani Hekmat A
    Virus Genes; 2024 Feb; 60(1):80-96. PubMed ID: 38079060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility.
    Tariq MA; Everest FLC; Cowley LA; Wright R; Holt GS; Ingram H; Duignan LAM; Nelson A; Lanyon CV; Perry A; Perry JD; Bourke S; Brockhurst MA; Bridge SH; De Soyza A; Smith DL
    mSystems; 2019 Jun; 4(4):. PubMed ID: 31164451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
    Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L
    Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lytic activity of phages against bacterial pathogens infecting diabetic foot ulcers.
    Kifelew LG; Warner MS; Morales S; Gordon DL; Thomas N; Mitchell JG; Speck PG
    Sci Rep; 2024 Feb; 14(1):3515. PubMed ID: 38347019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and Characterization of Lytic
    Akremi I; Merabishvili M; Jlidi M; Haj Brahim A; Ben Ali M; Karoui A; Lavigne R; Wagemans J; Pirnay JP; Ben Ali M
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates.
    Menon ND; Kumar MS; Satheesh Babu TG; Bose S; Vijayakumar G; Baswe M; Chatterjee M; D'Silva JR; Shetty K; Haripriyan J; Kumar A; Nair S; Somanath P; Nair BG; Nizet V; Kumar GB
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
    Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
    Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of broad-spectrum phiKZ like jumbo phage and its utilisation in controlling multidrug-resistant Pseudomonas aeruginosa isolates.
    Rai P; Shetty SS; Prabell S; Kuntar A; Pinto D; Kumar BK; Divyashree M; Raj JRM; Premanath R; Deekshit VK; Karunasagar I; Karunasagar I
    Microb Pathog; 2022 Nov; 172():105767. PubMed ID: 36096457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-antibiotic combinations against multidrug-resistant
    Holger DJ; El Ghali A; Bhutani N; Lev KL; Stamper K; Kebriaei R; Kunz Coyne AJ; Morrisette T; Shah R; Alexander J; Lehman SM; Rojas LJ; Marshall SH; Bonomo RA; Rybak MJ
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0057823. PubMed ID: 37855639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa.
    Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M
    Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and Characterization of New Bacteriophages against Staphylococcal Clinical Isolates from Diabetic Foot Ulcers.
    Plumet L; Morsli M; Ahmad-Mansour N; Clavijo-Coppens F; Berry L; Sotto A; Lavigne JP; Costechareyre D; Molle V
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140529
    [No Abstract]   [Full Text] [Related]  

  • 15. A single dose of a virulent bacteriophage vB PaeP-SaPL, rescues bacteremic mice infected with multi drug resistant Pseudomonas aeruginosa.
    Alvi IA; Asif M; Ur Rehman S
    Virus Res; 2021 Jan; 292():198250. PubMed ID: 33259872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing.
    Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ
    J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
    Vinodkumar CS; Kalsurmath S; Neelagund YF
    Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of lytic bacteriophages against
    Majdani R; Shams Ghahfarokhi E
    Iran J Microbiol; 2022 Apr; 14(2):203-213. PubMed ID: 35765555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients.
    Srivastava P; Sivashanmugam K
    Infect Genet Evol; 2021 Aug; 92():104824. PubMed ID: 33774177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.